银杏外种皮的双黄酮成分

从银杏外种皮的乙酸乙酯提取中分离得到６个化合物,其中５个经物理常数及光谱分析鉴定为金松双黄酮、银杏素、奶杏素、１－５’－甲氧基白果素及白果素。这些化合物均首次从银杏外种皮分离。     

植物定植图微机显示与管理系统

介绍了运用软件工程的方法和数据库技术研究开发的南京中山植物园植物定植图微机显示与管理系统。详细介绍了系统的目标,系统的实现,应用软件的研制及应用效果。     

戊肝病毒活性肽的选择,合成与应用

对戊型肝炎病毒（ＨＥＶ）编码蛋白序列进行了亲水性分析及二级结构预测,选择亲水性强、具有β－转角与β－折叠的区段,采用多肽固相合成法合成了ＨＥＶ基因组３个开读框架（ＯＲＦ１,ＯＲＦ２和ＯＲＦ３）中可能的抗原表位,以免疫学方法进行鉴定并选出了分别来自ＨＥＶ３个ＯＲＦ的、具有重要生物活性与应用前景的３段肽（ＥＨ１７４、ＥＨ２６５、ＥＨ３６２）。在此基础上,进行了抗ＨＥＶＥＬＩＳＡ新型检测试剂盒的实验室研究及临床试用。结果表明,所研究的戊肝抗体检测试剂盒特异性高、临床符合性好、具有可重复性,在戊肝辅助诊断及流行病学调查中具有重要意义。     

无色素腺棉籽蛋白粉与棉子油的制备

低棉酚棉籽为高蛋白含油的植物资源,适宜于水溶法制备油及蛋白粉,出油率一般可达９５％。     

新疆呼图壁盐化草甸群落的DCA, CCA及DCCA分析

 本文应用DCA、CCA及DCCA排序技术对新疆呼图壁盐化草甸群落进行了分析。分析中选取了地下水位、粘土层出现深度、粘土层厚度、地下水pH值及地下水矿化度5个环境因子;同时为了分析空间格局对植被分异影响的大小,建立了样地空间坐标矩阵。结果表明：地下水位和地下水的pH值是引起植被分异的两个主要因素,空间格局对植被分异的影响大于环境因子对植被分异的影响。     

凤凰木种子蛋白的分离提纯和生化性质

研究了植物凤凰木种子中的蛋白质成分,试图分离出新的核糖体失活蛋白凤凰木种子经磷酸盐缓冲液抽提,硫酸铵分级盐析,分子筛和阴离子交换剂等多次柱层析,分离出三种组分ＤｒⅠ、ＤｒⅡ和ＤｒⅢ．ＳＤＳ－ＰＡＧＥ和ＩＥＦ实验表明这三种蛋白质均达到单一纯,而ＨＰＬＣ实验则表明它们的纯度不低于９０％。它们的分子量据ＳＤＳ－ＰＡＧＥ和ＨＰＬＣ实验分别约２３５００、２６０００、２８５００．ＩＥＦ实验测得三者的等电点均为５．２左右。测定了组分ＤｒⅠ的蛙卵泡裂解活性,其毒性约为天花粉蛋白的１／４０．分析了它们的氨基酸组成。估算了三种蛋白质的二级结构含量,结果表明三者均富含β折叠结构。已有的实验事实表明这三种蛋白质的生化行为明显异于核糖体失活蛋白,因而很可能不属于这一蛋白质家族。     

Differential effects of corticotropin-releasing hormone on central dopaminergic and noradrenergic neurons

Corticotropin-releasing hormone (CRH) has been shown to be a central mediator for most, if not all, stress-induced responses. Since stressful stimuli may decrease hypothalamic tuberoinfundibular and tuberohypophysial dopaminergic neuronal activities, we aimed to determine whether CRH is involved. Using central administration of various doses of ovine CRH (oCRH; 1, 3 and 10 µg/rat) into the lateral cerebroventricle of either male or female rats, the neurochemical changes in various parts of the central nervous system, including the hypothalamus, were determined by high-performance liquid chromatography at various times after the injection (30, 60, 120 and 240 min). The concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxy-4-hydroxy-phenylethyleneglycol (MHPG), two major metabolites of dopamine and norepinephrine, respectively, in discrete brain regions were used as indices for catecholaminergic neuron activity. Plasma corticosterone levels increased significantly after all doses of oCRH and at all time points studied. oCRH also exerted significant stimulatory effects on noradrenergic neuron terminals in the frontal cortex, and on dopaminergic neuron terminals in the nucleus accumbens, hypothalamic paraventricular and periventricular nuclei, and intermediate pituitary lobe. Dopaminergic neuron terminals in the median eminence and the neural lobe of the pituitary, however, were not affected. There was no major difference in the responses between male and female rats. We conclude that CRH has a differential effect on central catecholaminergic neurons.     

Evidence that 5-HT2 antagonism elicits a 5-HT3-mediated increase in dopamine transmission

Amperozide, a novel atypical antipsychotic drug with few extrapyramidal side effects, is a strong serotonin₂ (5-HT₂) antagonist but has low affinity for dopamine receptors in vitro. The effect of amperozide on the dopaminergic synapse was studied with an in vivo microdialysis technique using anesthetized male Sprague-Dawley rats. Following implantation of dialysis probes into the striatum and nucleus accumbens (NuAc), amperozide was intravenously infused as six consecutive incremental doses (0.5, 0.5, 1.0, 2.0, 4.0 and 8.0 mg/kg) at intervals of 15 min. From the beginning of drug infusion, perfusates were collected in fractions every 30 min throughout a total period of 120 min. The samples were then immediately analyzed by high-performance liquid chromatography with electrochemical detection. Amperozide induced a dose-related elevation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindolacetic acid (5-HIAA) levels in both areas.p-Chlorophenylalanine (pCPA) pretreatment abolished the production of 5-HIAA in both areas and attenuated the amperozide-induced rise of DOPAC but not of dopamine. After pretreatment with an intravenous 5-HT₃ antagonist, MDL 72222, the amperozide-induced changes in dopamine, DOPAC and 5-HIAA in both areas were lower than in the saline control group. Preliminary data showed that afterpCPA pretreatment, incremental concentrations of the 5-HT₃ agonist 1-(m-chlorophenyl)-biguanide perfused via the probe also produced significant elevation of dopamine and DOPAC levels in these two areas. Taken together, these results suggest that amperozide may directly block 5-HT₂ receptors in the striatum and NuAc, thereby enhancing 5-HT transmission. The enhanced 5-HT transmission may activate postsynpatic 5-HT₃ receptors located on the dopaminergic terminals, leading to changes in dopamine transmission in these two areas.     

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.

Transforming growth factor beta (TGF-beta) is a potent inhibitor of epithelial cell growth. Cyclins E and A in association with Cdk2 have been shown to play a role in the G1-to-S phase transition in mammalian cells. We have studied the effects of TGF-beta-mediated growth arrest on G1/S cyclins E and A. Inhibition of cyclin A-associated kinase by TGF-beta is primarily due to a decrease in cyclin A mRNA and protein. By contrast, while TGF-beta inhibits accumulation of cyclin E mRNA, the reduction in cyclin E protein is minimal. Instead, we find that the activation of cyclin E-associated kinase that normally accompanies the G1-to-S phase transition is inhibited. A novel inhibitor of cyclin-Cdk complexes was detected in TGF-beta-treated cell lysates. Inhibition is mediated by a heat-stable protein that targets both Cdk2 and Cdc2 kinases. In G0-arrested cells, a similar inhibitor of Cdk2 kinase was detected. These data suggest the existence of an inhibitor of cyclin-dependent kinases induced under different conditions to mediate antiproliferative responses.